Validation of Guanidine-EDTA as a Preservative Agent for the Analysis of miRNAs and mRNAs in Blood Samples of Chagas Disease Patients
Pathogens · 14.04.2026 · 15 (4) · 424
DOI: 10.3390/pathogens15040424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 14.04.2026. Verfasst von Amanda Faier-Pereira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Platform of Molecular Analysis, Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21…. Hauptthemen laut MEDLINE: RNA, Messenger, MicroRNAs, Chagas Disease, Edetic Acid. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development, FAPERJ.
Abstract (Originalsprache)
Chagas disease (CD) is a neglected tropical disease caused by the flagellate protozoan Trypanosoma cruzi, representing a major socioeconomic challenge. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression, and several pathogens, including T. cruzi, can modulate host miRNA networks. In this context, we hypothesized that host-derived miRNAs could serve as biomarkers in chronic CD. Given the intrinsic lability of RNA, we evaluated the efficacy of a 6 M guanidine-HCl/0.2 M EDTA solution, widely used in the molecular detection of T. cruzi DNA, in preserving mRNAs and miRNAs when mixed in a 1:1 ratio with human blood. Samples with or without guanidine were enriched with exogenous miRNAs (cel-miR-39 and cel-miR-54) and stored at 4 °C. RNase P expression was also evaluated in blood samples stored for up to 120 days and in samples from patients with CD, allowing direct comparison of mRNA stability over time. Samples preserved with guanidine-EDTA showed Ct values that were 4 to 5 cycles lower for all targets analyzed and demonstrated greater RNA stability over time. Taken together, these findings demonstrate that guanidine-EDTA robustly preserves mRNA and miRNAs in human blood, expanding the feasibility of molecular analyses in retrospective samples and corroborating its potential application in the studies of biomarkers of therapeutic response and prognosis in CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Platform of Molecular Analysis, Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, RJ, Brazil.
- Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, RJ, Brazil.
ORCID-Profile: Amanda Faier-Pereira, Paula Finamore-Araujo, Alejandro Marcel Hasslocher-Moreno, Otacilio C Moreira
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
- FAPERJ
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES
- CNPq B
Zitieren
APA
Faier-Pereira, A., Finamore-Araujo, P., Brito, M. M. R., Hasslocher-Moreno, A. M., & Moreira, O. C. (2026). Validation of Guanidine-EDTA as a Preservative Agent for the Analysis of miRNAs and mRNAs in Blood Samples of Chagas Disease Patients. Pathogens, 15(4), 424. https://doi.org/10.3390/pathogens15040424
Vancouver
Faier-Pereira A, Finamore-Araujo P, Brito MMR, Hasslocher-Moreno AM, Moreira OC. Validation of Guanidine-EDTA as a Preservative Agent for the Analysis of miRNAs and mRNAs in Blood Samples of Chagas Disease Patients. Pathogens. 2026;15(4):424. doi:10.3390/pathogens15040424
BibTeX
@article{FaierPereira2026,
author = {Faier-Pereira, Amanda and Finamore-Araujo, Paula and Brito, Maria Mikaely Ribeiro and Hasslocher-Moreno, Alejandro Marcel and Moreira, Otacilio C},
title = {Validation of Guanidine-EDTA as a Preservative Agent for the Analysis of miRNAs and mRNAs in Blood Samples of Chagas Disease Patients},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {4},
pages = {424},
doi = {10.3390/pathogens15040424}
}
EUVIMED